Temasek Holdings Private Ltd cut its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 38.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 67,914 shares of the semiconductor company's stock after selling 42,386 shares during the quarter. Temasek Holdings Private Ltd's holdings in Synopsys were worth $32,963,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. James Hambro & Partners LLP lifted its holdings in shares of Synopsys by 30.9% during the fourth quarter. James Hambro & Partners LLP now owns 201,460 shares of the semiconductor company's stock worth $97,725,000 after buying an additional 47,527 shares in the last quarter. Janney Capital Management LLC bought a new stake in Synopsys in the 4th quarter valued at about $6,082,000. Artemis Investment Management LLP boosted its holdings in Synopsys by 4.5% in the 4th quarter. Artemis Investment Management LLP now owns 24,878 shares of the semiconductor company's stock valued at $12,075,000 after purchasing an additional 1,081 shares during the period. Fiera Capital Corp grew its position in shares of Synopsys by 33.8% during the 4th quarter. Fiera Capital Corp now owns 196,391 shares of the semiconductor company's stock worth $95,320,000 after purchasing an additional 49,653 shares in the last quarter. Finally, Bancreek Capital Management LP bought a new position in shares of Synopsys during the fourth quarter worth approximately $3,827,000. 85.47% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Synopsys
In other news, insider Geus Aart De sold 15,705 shares of the company's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the completion of the sale, the insider now owns 116,671 shares in the company, valued at $51,850,925.82. This represents a 11.86% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the sale, the chief executive officer now owns 70,922 shares of the company's stock, valued at approximately $32,890,077.50. This represents a 13.81% decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by insiders.
Synopsys Trading Down 0.1%
NASDAQ SNPS traded down $0.40 on Tuesday, hitting $515.61. 740,736 shares of the company were exchanged, compared to its average volume of 1,107,856. The company has a market cap of $79.72 billion, a PE ratio of 35.51, a PEG ratio of 3.23 and a beta of 1.16. The stock has a fifty day moving average of $447.85 and a 200-day moving average of $489.13. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $624.80.
Analyst Ratings Changes
SNPS has been the topic of a number of analyst reports. Rosenblatt Securities reissued a "buy" rating and set a $660.00 price target on shares of Synopsys in a research report on Tuesday, February 25th. Wells Fargo & Company decreased their price target on Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 27th. Mizuho cut their price objective on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. KeyCorp raised their target price on shares of Synopsys from $555.00 to $575.00 and gave the company an "overweight" rating in a report on Tuesday. Finally, Piper Sandler reduced their price target on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $614.86.
Get Our Latest Report on Synopsys
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.